Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 16.35
-0.19 (-1.15%)
Aug 15, 2025, 4:10 PM AEST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 2.06 billion as of August 15, 2025. Its market cap has decreased by -13.45% in one year.
Market Cap
2.06B
Enterprise Value
1.84B
Revenue
216.83M
Ranking
n/a
PE Ratio
15.05
Stock Price
16.35
Market Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 2.06B, an increase of 9,759.23%. That is a compound annual growth rate of 25.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 2.06B | 29.95% |
| Dec 31, 2024 | 1.59B | -50.04% |
| Dec 29, 2023 | 3.18B | 217.33% |
| Dec 30, 2022 | 1.00B | 110.88% |
| Dec 31, 2021 | 474.89M | 222.46% |
| Dec 31, 2020 | 147.27M | -40.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 130.52B |
| Pro Medicus | 31.04B |
| Cochlear | 20.49B |
| Sonic Healthcare | 13.81B |
| Ramsay Health Care | 8.92B |
| Telix Pharmaceuticals | 5.80B |
| Ansell | 4.57B |
| Mesoblast | 2.97B |